01.27.14
A new study examining the efficacy of kollaGen I.V.X. HEM from Certified Nutraceuticals, found that the 100% hydrolyzed collagen avian egg membrane ingredient was a beneficial for the management of joint and connective tissue disease, symptoms, and related side effects. The study in particular noted an excellent response for participants suffering from Osteoarthritis.
The 20 study participants were ages 21 years to 80 years (10 males / 10 females) with confirmed joint damage, cartilage injuries, and skin disorders, diagnosed with imaging/scoping with low to high pain scales. Participants were administered the optimal dosage of 500 mg of kollaGen I.V.X. HEM daily, taken with citric juice on an empty stomach.From there, the goal of the trial was to examine the effectiveness of this substance on patients with symptoms associated with Osteoarthritis and related inflammatory diseases/conditions.
Supplementation with Hydrolyzed Egg Membrane produced a significant treatment response at seven days for flexibility (74.5% increase; P = 0.035) and at 60 days for general pain (91.7% reduction; P = 0.006), flexibility (70.6% increase; P =0.006) and range of motion associated pain (77.3% reduction; P = 0.020). There were no adverse events reported during the study and the treatment was reported to be well tolerated by study participants.
A clinical trial dosage of 500 mg taken once per day had a rapid response effect within a 7-day period and over 70% at day 14. The participants’ clinical picture continued upward to 60 days into the trial, receiving the full weight of the substances capabilities to reduce pain, inflammation, and swelling to regional swelling to some degree. The participant’s quality of life had increased upwards of 80% after the conclusion of the trial.
Researchers concluded that hydrolyzed egg membrane should be considered a viable option for the treatment/management of joint and connective tissue disease/disorders, and marked pain syndrome with a substantial reduction of symptoms.
For more information: www.certifiednutra.com
The 20 study participants were ages 21 years to 80 years (10 males / 10 females) with confirmed joint damage, cartilage injuries, and skin disorders, diagnosed with imaging/scoping with low to high pain scales. Participants were administered the optimal dosage of 500 mg of kollaGen I.V.X. HEM daily, taken with citric juice on an empty stomach.From there, the goal of the trial was to examine the effectiveness of this substance on patients with symptoms associated with Osteoarthritis and related inflammatory diseases/conditions.
Supplementation with Hydrolyzed Egg Membrane produced a significant treatment response at seven days for flexibility (74.5% increase; P = 0.035) and at 60 days for general pain (91.7% reduction; P = 0.006), flexibility (70.6% increase; P =0.006) and range of motion associated pain (77.3% reduction; P = 0.020). There were no adverse events reported during the study and the treatment was reported to be well tolerated by study participants.
A clinical trial dosage of 500 mg taken once per day had a rapid response effect within a 7-day period and over 70% at day 14. The participants’ clinical picture continued upward to 60 days into the trial, receiving the full weight of the substances capabilities to reduce pain, inflammation, and swelling to regional swelling to some degree. The participant’s quality of life had increased upwards of 80% after the conclusion of the trial.
Researchers concluded that hydrolyzed egg membrane should be considered a viable option for the treatment/management of joint and connective tissue disease/disorders, and marked pain syndrome with a substantial reduction of symptoms.
For more information: www.certifiednutra.com
